HR
IHE icon

Howe & Rusling’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Howe & Rusling’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-84
Closed -$5.93K – 436
2024
Q3 		$5.93K Buy
+84
New +$5.85K ﹤0.01% 367

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Howe & Rusling's IHE Position: Q4 2024 in Review

Howe & Rusling sold out of iShares US Pharmaceuticals ETF (IHE) in Q4 2024, closing a stake of 84 shares — an estimated $5.93K sold.

Howe & Rusling first reported a position in IHE in Q3 2024 and held it in 1 quarter. The position peaked at $5.93K in Q3 2024. 155 funds tracked by Wall St. Rank hold IHE as of Q4 2024.

  • Howe & Rusling reported no remaining iShares US Pharmaceuticals ETF position as of Q4 2024 after selling out during the quarter.
  • Howe & Rusling sold 84 iShares US Pharmaceuticals ETF shares in Q4 2024, an estimated $5.93K.
  • Howe & Rusling first reported a position in iShares US Pharmaceuticals ETF in Q3 2024 and held it in 1 quarter.
  • Howe & Rusling's iShares US Pharmaceuticals ETF position peaked at $5.93K in Q3 2024.
  • 155 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q4 2024.

Based on Howe & Rusling's 13F filing for Q4 2024, filed 12 Feb 2025.